Table 2.
Association of Hormones With Sexual Function, Vitality, and Physical Function
Outcome | Total T |
Free T |
Estradiol |
SHBG |
||||
---|---|---|---|---|---|---|---|---|
ß (95% CI) | P | ß (95% CI) | P | ß (95% CI) | P | ß (95% CI) | P | |
Sexual Functiona | ||||||||
(Sexual Function Trial Only) | ||||||||
DISF | 0.009 (0.001, 0.018) | 0.034 | 0.037 (0.006, 0.068) | 0.020 | 0.035 (−0.028, 0.097) | 0.275 | −0.016 (−0.059, 0.023) | 0.469 |
IIEF | 0.016 (0.005, 0.027) | 0.004 | 0.056 (0.017, 0.094) | 0.005 | 0.047 (−0.030, 0.124) | 0.230 | −0.049 (−0.102, 0.005) | 0.074 |
PDQ-Q4 | 0.002 (0.000, 0.004) | 0.024 | 0.008 (0.002, 0.014) | 0.014 | 0.012 (−0.000, 0.024) | 0.051 | −0.006 (−0.014, 0.003) | 0.185 |
Sexual Functiona | ||||||||
(All T-Trial Participants) | ||||||||
DISF | 0.008 (−0.000, 0.016) | 0.055 | 0.048 (0.020, 0.077) | <0.001 | 0.060 (0.003, 0.117) | 0.039 | −0.047 (−0.085, −0.009) | 0.016 |
IIEF | 0.014 (0.004, 0.246) | 0.005 | 0.049 (0.013, 0.085) | 0.008 | 0.047 (−0.023, 0.122) | 0.218 | −0.046 (−0.097, 0.004) | 0.073 |
PDQ-Q4 | 0.002 (0.000, 0.003) | 0.026 | 0.008 (0.003, 0.013) | 0.003 | 0.012 (0.002, 0.022) | 0.022 | −0.006 (−0.013, 0.001) | 0.078 |
Vitality Trialb | ||||||||
FACIT Fatigue | 0.005 (−0.003, 0.013) | 0.217 | 0.000 (−0.030, 0.031) | 0.982 | 0.001 (−0.058, 0.061) | 0.962 | 0.016 (−0.022, 0.054) | 0.401 |
PHQ-9 | −0.003 (−0.008, 0.002) | 0.290 | −0.006 (−0.026, 0.013) | 0.527 | −0.009 (−0.046, 0.029) | 0.657 | 0.012 (−0.013, 0.036) | 0.347 |
Physical Function Trialb | ||||||||
Gait Speed (m/s) | 0.000 (−0.000, 0.000) | 0.314 | 0.001 (−0.000, 0.002) | 0.231 | −0.002 (−0.004, 0.000) | 0.104 | −0.001 (−0.002, 0.000) | 0.112 |
PF-10 | −0.003 (−0.033, 0.027) | 0.824 | 0.004 (−0.100, 0.108) | 0.938 | −0.311 (−0.530, −0.092) | 0.006 | −0.068 (−0.199, 0.063) | 0.308 |
Abbreviations: DISF, Derogatis Interview for Sexual Function-Sexual Desire Domain.
Adjusted for BMI, age, hypertension, diabetes, and waist circumference.
Adjusted for age and BMI.